PB 38 of 2016

National Health (Originator Brand) Amendment Determination 2016 (No. 3)

National Health Act 1953

I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Determination under subsection 99ADB (6B) of the National Health Act 1953.

Dated         29  April 2016

 

 

 

 

 

 

_____________________________________

ADRIANA PLATONA

Assistant Secretary

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health

 

1 Name of Determination

 (1) This Determination is the National Health (Originator Brand) Amendment Determination 2016 (No. 3).

(2) This Determination may also be cited as PB 38 of 2016.

2 Commencement

  This Determination commences on 1 May 2016.

3 Amendments to PB 100 of 2015

  Schedule 1 amends the National Health (Originator Brand) Determination 2015 (PB 100 of 2015).

 

 

Schedule 1 Amendments

(section 3)

 

[1] Schedule 1 (after table item 78)

Insert:

 

78A

Esomeprazole and Clarithromycin and Amoxycillin

Nexium Hp7